These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2174971)

  • 1. Specificity of anti-Scl-70 antibodies in scleroderma: increased sensitivity of detection using purified DNA topoisomerase I from calf thymus.
    Tsay GJ; Fann RH; Hwang J
    J Rheumatol; 1990 Oct; 17(10):1314-9. PubMed ID: 2174971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-topoisomerase-I and clinical findings in systemic sclerosis (scleroderma).
    Shoenfeld Y; Grunebaum E; Laufer M; Zurgil N; Bakimer R; Lunderschmidt A; Valentini G; Tirri G; Blank M
    Isr J Med Sci; 1996 Jul; 32(7):537-42. PubMed ID: 8756980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scl-86, a marker antigen for diffuse scleroderma.
    van Venrooij WJ; Stapel SO; Houben H; Habets WJ; Kallenberg CG; Penner E; van de Putte LB
    J Clin Invest; 1985 Mar; 75(3):1053-60. PubMed ID: 3980727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-topoisomerase I autoantibodies in systemic sclerosis.
    Czömpöly T; Simon D; Czirják L; Németh P
    Autoimmun Rev; 2009 Jul; 8(8):692-6. PubMed ID: 19393194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to topoisomerase I in sera from patients with scleroderma.
    Shero JH; Bordwell B; Rothfield NF; Earnshaw WC
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():138-40. PubMed ID: 3039129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibodies against topoisomerase I (Scl-70)--comparative studies on detection with recombinant protein antigens and natural enzyme].
    Seelig HP; Schröter H; Ehrfeld H; Renz M
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):505-11. PubMed ID: 7856253
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoblotting on HEp-2 cells increases the detection of antitopoisomerase 1 antibodies in patients with systemic sclerosis.
    Tamby MC; Servettaz A; Guilpain P; Tamas N; Berezné A; Batteux F; Reinbolt J; Guillevin L; Weill B; Mouthon L
    Clin Immunol; 2007 Apr; 123(1):82-8. PubMed ID: 17258939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
    Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
    Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-idiotypic antibodies to topoisomerase I in serum from patients with autoimmune diseases].
    Bronshteĭn IB; Shuster AM; Gromova II; Krashuk OA; Geva ON; Alekberova ZS; Gabibov AG
    Dokl Akad Nauk SSSR; 1991; 318(6):1496-500. PubMed ID: 1655373
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-topoisomerase I (anti-Scl-70) antibodies in patients with systemic lupus erythematosus.
    Gussin HA; Ignat GP; Varga J; Teodorescu M
    Arthritis Rheum; 2001 Feb; 44(2):376-83. PubMed ID: 11229469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients.
    Hénault J; Robitaille G; Senécal JL; Raymond Y
    Arthritis Rheum; 2006 Mar; 54(3):963-73. PubMed ID: 16508979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scl-70 antigen stability and its effect on antibody detection in scleroderma.
    Kumar V; Kowalewski C; Koelle M; Qutaishat S; Chorzelski TP; Beutner EH; Jarzabek-Chorzelska M; Kolacinska Z; Jablonska S
    J Rheumatol; 1988 Oct; 15(10):1499-502. PubMed ID: 3144599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to topoisomerase I (Scl-70): analysis by gel diffusion, immunoblot, and enzyme-linked immunosorbent assay.
    Hildebrandt S; Weiner ES; Senecal JL; Noell GS; Earnshaw WC; Rothfield NF
    Clin Immunol Immunopathol; 1990 Dec; 57(3):399-410. PubMed ID: 2173985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
    Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PM1-Alpha ELISA: the assay of choice for the detection of anti-PM/Scl autoantibodies?
    Mahler M; Fritzler MJ
    Autoimmun Rev; 2009 Mar; 8(5):373-8. PubMed ID: 19103309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-scl-70.
    Basu D; Reveille JD
    Autoimmunity; 2005 Feb; 38(1):65-72. PubMed ID: 15804707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma.
    Hayakawa I; Hasegawa M; Takehara K; Sato S
    Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody specificities of Thai and Australian scleroderma sera with topoisomerase I recombinant fusion proteins.
    Cram DS; Fisicaro N; McNeilage LJ; Coppel RL; Harrison LC
    J Immunol; 1993 Dec; 151(12):6872-81. PubMed ID: 7505017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical significance of detecting the inhibition of topoisomerase I by the sera of patients with systemic scleroderma].
    Shcherbakov AB; Remenson EI; Kirsanova ID; Basnak'ian AG; Guseva NG
    Ter Arkh; 1992; 64(5):73-5. PubMed ID: 1333647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity and plasticity of the anti-DNA topoisomerase I autoantibody response in scleroderma.
    Henry PA; Atamas SP; Yurovsky VV; Luzina I; Wigley FM; White B
    Arthritis Rheum; 2000 Dec; 43(12):2733-42. PubMed ID: 11145031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.